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Abstract
Background: In children, the most significant cause of rhabdomyolysis or muscle breakdown is viral infection.
However, there are no reports that norovirus, a gastroenteric virus that commonly infects children, specifically
causes rhabdomyolysis. Here, we report the first pediatric case of norovirus-associated rhabdomyolysis.
Case presentation: The patient, a 2-year-old boy with fever, diarrhea, and vomiting, was referred to our hospital
with dysstasia and transaminitis. He was diagnosed with rhabdomyolysis. Additionally, norovirus genogroup GII
was detected from stool samples by real-time quantitative reverse transcription Polymerase Chain Reaction, and
thereafter, the norovirus GII.4 variant was identified.
Conclusion: However, the association between rhabdomyolysis and the isolated norovirus variant was not clarified.
After treatment the patient recovered without renal failure or disseminated intravascular coagulation. Rhabdomyolysis
is a disease for which there is a need for early detection and treatment. If abnormal posture or muscle weakness is
observed during the course of gastroenteritis, blood and urinary tests should be performed to rule out rhabdomyolysis.
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Background
Due to decreased incidence of rotavirus as the result of
the rotavirus vaccine, norovirus has become the leading
cause of acute gastroenteritis in children less than 2 years
old in Japan as well as in the USA [1, 2]. Rhabdomyoly-
sis, muscle breakdown, in children is caused by acute
viral infections such as influenza A/B, coxsackievirus,
and Epstein-Barr virus [3]. In up to 40 % of children
with rhabdomyolysis, renal failure is reported to develop.
Delay in the detection of rhabdomyolysis may increase
the risk of development of acute renal failure [4]. There-
fore, early diagnosis and initiation of appropriate treat-
ments for rhabdomyolysis is crucial. However, infants
and young children are unable to clearly complain of
these symptoms and thus require close examination.
Here we report the first case describing rhabdomyolysis
in a norovirus-infected child.
Case presentation
The patient, an ethnically Japanese 2-year-old boy, was
referred to our hospital with dysstasia and transaminitis.
In Fig. 1, representative clinical manifestation and la-
boratory data are shown. The boy was well since birth
until the onset of illness. On the first day, he developed
a fever and was treated with acetaminophen suppositor-
ies. On the second day after onset of illness, his family
took him to a nearby clinic because of the persistent
fever, along with diarrhea and vomiting. Additionally,
the child was unable to stand. A rapid diagnostic test for
influenza A and B viral antigens yielded negative results.
Although the fever subsided on the third day, the child
was still unable to stand and was taken to the clinic again
(Fig. 1). Physical examination showed muscle weakness in
the lower extremities. Blood examination revealed high
levels of transaminases, indicative of rhabdomyolysis.
Thus, the child was admitted to our hospital.
On admission (11 January 2012), there was no fever,
and the child was awake and alert. Vital signs were nor-
mal, except for slight tachycardia. Examination of the
chest and abdomen revealed no abnormalities. There
was no swelling, warmth, or tenderness of the joints or
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muscles of the extremities. Muscle weakness and blunted
deep tendon reflexes were noted in the lower limbs. The
child had been able to walk independently prior to the
onset of this illness; however, he was now unable to stand
up or maintain a stable sitting position (Fig. 1).
Normal white blood cell (WBC) and slight increase of
C-reactive protein were observed. Serum electrolyte
levels were normal. Blood urea nitrogen (BUN) and
serum creatinine (Cr) were within normal limits. Normal
serum levels of bilirubin, cholinesterase, and ammonia
were observed, as well as normal blood levels of glucose
lactate and acidosis. The child also presented a normal
coagulation profile. Serum levels of aspartate amino-
transferase (AST) (2, 334 U/L), alanine aminotransferase
(ALT) (823 U/L), lactate dehydrogenase (LDH) (4, 291
U/L) and creatine kinase (CK) (100, 637 U/L) were ele-
vated (Fig. 1). The levels of the three main isoforms of
serum CK (MM, MB, and BB) were 100, 0, and 0 %, re-
spectively, indicating a muscular rather than cardiac ori-
gin of rhabdomyolysis. High serum and urinary levels of
myoglobin (3, 680 ng/mL and 11, 000 ng/mL, respect-
ively) were also observed (Fig. 1). Qualitative urinalysis
yielded a positive occult blood test; however, the urinary
sediment revealed no red blood cells.
To understand the viral cause of the presented patient’s
symptoms, we systematically tested for a battery of viruses.
From a stool sample taken upon admission, the norovirus
genogroup was determined by real-time quantitative
reverse transcription (RT)-PCR [5]. For the detection of
norovirus GI, primers COG1F and COG1R and probes
RING1-TP(a) and RING1-TP(b) were used. For the detec-
tion of norovirus GII, primers COG2F/ALPF and COG2R,
and probe RING2AL-TP were used [5]. Norovirus GII was
moderately detected (3.7× 107 copies/g feces); however,
norovirus GI was not. To analyze the genotype of the de-
tected norovirus GII strain, the partial capsid gene products
were amplified by PCR using the primer sets COG2F/G2-
SKR (387 bp) [5] (http://www.mhlw.go.jp/topics/syokuchu/
kanren/kanshi/031105-1a.pdf).
The genotype of the norovirus was characterized by dir-
ect nucleotide sequencing of the partial capsid gene and
was then identified with norovirus GII.4 Den_Haag_2006b
variant according to the Norovirus Genotyping Tool Ver-
sion 1.0 (http://www.rivm.nl/mpf/norovirus/typingtool).
A pharynx swab taken upon admission was examined
for enteroviral subgroups (coxsackieviruses, echoviruses,
and enteroviruses) by RT-PCR; however, none was de-
tected. A stool sample taken on the fifth day after illness
onset, examined by the latex agglutination test, was
negative for both rotavirus and adenovirus infections.
Additionally, results of serum tests for HBs antigen and
HCV antibody were negative. Serum test results for IgM
antibodies against Epstein-Barr virus, herpes simplex
virus, and cytomegalovirus were negative. Soon after ad-
mission, we attempted to isolate pathogenic bacteria
from a stool sample by conventional methods; however,
none was found. From these bacterial and viral labora-
tory results, the most plausible causative pathogen for
rhabdomyolysis was norovirus.
Treatment was initiated with intravenous administra-
tion of bicarbonate Ringer’s solution and oral adminis-
tration of the diuretic acetazolamide. On the sixth day
after onset of illness, we found that the therapies could
be discontinued without the development of renal failure
or disseminated intravascular coagulation. On the sev-
enth day, the deep tendon reflexes became normal, and
the child moved his legs often in the supine position. On
the eighth day, serum and urinary myoglobin levels had
Fig. 1 Representative clinical manifestation and laboratory data
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improved to 238 ng/mL and <10 ng/mL, respectively.
The patient was able to maintain a stable sitting position
and was discharged from the hospital (Fig. 1).
Discussion
Norovirus infection is known to be associated with various
complications, including rash, convulsive attacks, enceph-
alopathy, ileus, invagination, hemophagocytic syndrome,
and metabolic acidosis. However, the association with
norovirus infection and rhabdomyolysis has never been
reported. Mannix et al. investigated 191 children with
rhabdomyolysis and reported that the most frequent cause
was viral myositis (38.2 %). Other causes included trauma
(25.7 %), connective tissue diseases (5.2 %), drug overdose
(4.2 %), exercise (4.2 %), and metabolic disorders (3.7 %)
[6]. Rhabdomyolysis has been reported to develop follow-
ing various viral infections [3]. In our present case, influ-
enza virus, enteroviral subgroups, rotavirus, adenovirus,
hepatitis B virus, hepatitis C virus, Epstein-Barr virus, her-
pes simplex virus, and cytomegalovirus were ruled out by
our laboratory data. A search of the literature on rhabdo-
myolysis associated with viral gastroenteritis revealed only
one report of rhabdomyolysis associated with rotavirus in-
fection [7]. This report stated that the patient developed
encephalopathy, rhabdomyolysis, hypotensive shock and
severe electrolyte abnormalities [7].
In children with organic and fatty acid metabolic dis-
orders, rhabdomyolysis can be triggered by infection,
stress, and starvation [8]. However, the patient’s levels of
blood carnitine and urinary organic acids on admission
were normal (data not shown); therefore, organic and
fatty acid metabolic disorders (but not all metabolic dis-
eases) can be excluded. Except for the period of hospital
admission at age 2, the patient has been well from birth
until his present age of 6 years old. The vital signs at the
first visit to our hospital were stable, making it unlikely
that the patient had rhabdomyolysis, which is associated
with inborn errors of metabolism and mitochondrial
disease. There was no history of trauma, severe exercise
or heat stress. The laboratory test results upon admis-
sion showed no electrolyte abnormalities or severe in-
flammatory reactions. There was no evidence of alcohol
consumption or drug overdose. These observations
strongly suggested that the rhabdomyolysis was caused
by viral myositis.
From 2009 to 2013, the incidence of viral acute gastro-
enteritis among 2,381 Japanese pediatric patients was
examined by Thongprachum et al. [9]. Norovirus was pre-
dominantly detected (39.3 %), whereas the prevalence of
rotavirus, human parechovirus, enterovirus, and adeno-
virus was 20.1, 6.6, 6.1, and 5.6 %, respectively [9]. The
molecular epidemiology of norovirus genotypes in this
population were also analyzed by Thongprachum et al.
[10]. Noroviruses are highly diverse and can be divided into
five genogroups (GI, II, III, IV and V) [9]. Norovirus GII,
which is the most common genogroup of acute gastro-
enteritis, was detected in our patient’s fecal specimen.
When this patient was admitted (January 2012), the noro-
virus GII.4 genotype Den_Haag_2006b variant (43.2 %)
was the most common genotype, and then the norovirus
GII.4 genotype New_Orleans_2009 variant (17.8 %) co-
circulated until March 2012 based on work by Thongpra-
chum et al. [10]. Subsequently, they were displaced by the
norovirus GII.4 genotype Sydney_2012 variant [10]. We
isolated the norovirus genotype GII.4 Den_Haag_2006b
variant from our patient upon his admission, which cor-
roborates this epidemiological report [10].
Conclusion
This is the first plausible pediatric patient with noro-
virus and rhabdomyolysis development. The association
between rhabdomyolysis, the norovirus GII.4 genotype
Den_Haag_2006b variant, and the antigenicity of this
GII.4 variant against muscle cells (and thus being re-
sponsible for rhabdomyolysis) remains obscure and is
worthy of investigation.
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